An Open-Label Dose-Escalation Study of Once-Daily and Twice-Daily Pasireotide in Healthy Volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Open-Label Dose-Escalation Study of Once-Daily and Twice-Daily Pasireotide in Healthy Volunteers

Published:2014-05 Issue:3 Volume:21 Page:164-173
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Shenouda Magdy,Maldonado Mario,Wang Yanfeng,Bouillaud Emmanuel,Hudson Michelle,Nesheiwat Dalal,Hu Ke

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference13 articles.

1. . Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.;Ambrosi;J Endocrinol Invest,1990

2. The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelsons syndrome and Cushings disease.;Lamberts;Acta Endocrinol (Copenh),1989

3. . SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.;Bruns;Eur J Endocrinol,2002

4. Pasireotide (SOM230): development, mechanism of action and potential applications.;Schmid;Mol Cell Endocrinol,2008

5. . The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas.;Batista;J Clin Endocrinol Metab,2006

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of pasireotide-induced hyperglycemia in patients with acromegaly: An experts’ consensus statement;Frontiers in Endocrinology;2024-02-09

2. Pharmacokinetics and Safety of Long-Acting Release Formulations of Pasireotide (SOM230) in a Male Population Who Are Hyperendemic Hepatitis B/C and Chronic Kidney Disease: An Open-Label, Phase I Study;European Journal of Drug Metabolism and Pharmacokinetics;2023-09-26

3. Drug treatment strategies for secondary diabetes in patients with acromegaly;Expert Opinion on Pharmacotherapy;2020-07-07

4. A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals;Obesity Surgery;2019-11-10

5. Cushing Disease: Diagnosis and Treatment;Pituitary Disorders of Childhood;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3